After more than 15 years, the battle between the Canada Revenue Agency and Glaxo Canada over the transfer price for ranitidine—the active pharmaceutical ingredient used to make the branded, anti-ulcer drug Zantac—finally reached the Supreme Court of Canada (SCC) last month.
Transfer pricing consultants recognized by industry
Rebel Curd, David Kemp, Anna Soubbotina, and Paul Wilmshurst have been ranked by three key publications: Legal Media Group’s Expert Guide 2021, International...